Another Rapid COVID-19 Test Shows Promise


FRIDAY, Sept. 18, 2020 (HealthDay News) — Yet another rapid COVID-19 test has proven its mettle in spotting infection with the new coronavirus, this time in a British study.

The lab-in-a-cartridge testing device — which can be performed at bedside, doesn’t require a laboratory, and can be performed in cartridges smaller than a mobile phone — was tested on 386 National Health Service staff and patients in Britain.

The test had 94% sensitivity and 100% specificity, meaning it had a high level of accuracy and produced very few false negatives and no false positives. The results are available within 90 minutes, while conventional COVID-19 tests provide results within 24 hours, the researchers said. The findings were published Sept. 17 in The Lancet Microbe journal.

In the United States, four rapid coronavirus tests have already been developed. These tests detect COVID-19 antigens, proteins found on the surface of the coronavirus, rather than the virus itself, according to the Associated Press. It’s considered a faster, but less precise, screening method.

One of these tests, made by Abbott Laboratories and called BinaxNOW, has already secured a $760 million deal with the White House to produce 150 million rapid nasal swab tests for community testing, according to the AP.

The 15-minute BinaxNOW test will sell for $5, giving it an edge over similar tests that need to be popped into a small machine, the AP reported. No larger than a credit card, the Abbott test is based on the same technology used to test for the flu, strep throat and other infections.

“Those [rapid] screening tests are what we need in schools, workplaces and nursing homes in order to catch asymptomatic spreaders,” Dr. Jonathan Quick, an adjunct professor of global health at Duke University in North Carolina, told the AP.

With the British test, a nose swab from a patient is inserted into the cartridge device, which analyzes the sample for genetic material belonging to SARS-CoV-2 virus.

The new test is being used at eight London hospitals, and is due to be rolled out at a national level. The U.K. government recently placed an order for 5.8 million of the testing kits.



Source link

Discover

Sponsor

Latest

Intel, Mattel, Gilead Sciences & more

A visitor at Intel's Artificial Intelligence (AI) Day walks past a signboard during the event in Bangalore, IndiaManjunath Kiran | GettyCheck out the...

UPS CEO Carol Tome prepares company for coronavirus vaccine shipping

UPS CEO Carol Tome meets with workersSource: UPSCarol Tome has led UPS through a pandemic-fueled surge, what may turn out to be the...

Body Shop will buy 600 tons of waste plastic

LONDON — Plastic pollution is a massive problem: more than a billion tons of plastic waste will end up in oceans or in...

Lebanon’s powerhouse Hezbollah hit by backlash after blast

A woman hold a banner shows the name of victims of Beirut Explosion during a protest near the port, on August 11, 2020...

Tesla jumps nearly 11%, rebounding from worst day on record

Tesla shares jumped ahead of the close on Wednesday, finishing the session 10.92% higher as the auto maker regained some ground after Tuesday's...